A detailed history of Marshall Wace, LLP transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Marshall Wace, LLP holds 5,372 shares of PPH stock, worth $509,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,372
Holding current value
$509,641
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.87 - $93.23 $455,921 - $500,831
5,372 New
5,372 $491,000
Q3 2023

Nov 14, 2023

BUY
$76.26 - $83.18 $592,997 - $646,807
7,776 New
7,776 $620,000
Q4 2022

Feb 14, 2023

BUY
$67.31 - $79.26 $37,491 - $44,147
557 Added 4.42%
13,155 $1.02 Million
Q3 2022

Nov 14, 2022

BUY
$66.73 - $77.98 $489,130 - $571,593
7,330 Added 139.14%
12,598 $848,000
Q2 2022

Aug 15, 2022

BUY
$72.65 - $83.96 $45,624 - $52,726
628 Added 13.53%
5,268 $404,000
Q1 2022

May 16, 2022

BUY
$73.73 - $80.41 $342,107 - $373,102
4,640 New
4,640 $370,000

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.